Volume 28, Number 11—November 2022
Dispatch
Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
Table 1
Healthcare activity and IPD incidence by age group, Catalonia, Spain, 2018–2019 and 2020*
Variable | No. cases (incidence, cases/100,000 population) |
IRR (95% CI) | p value | |
---|---|---|---|---|
Mean 2018–19 | 2020 | |||
All ages | ||||
Emergency department visits | 227,148 (43,661.3) | 148,637 (28,437.6) | 0.65 (0.64–0.66) | <0.0001 |
Hospital admissions | 11,313 (2,174.5) | 8,423 (1,611.5) | 0.74 (0.72–0.76) | <0.0001 |
Samples for culture, HSJD | 7,489 (1,439.5) | 7,106 (1,359.5) | 0.94 (0.91–0.98) | 0.001 |
Samples for PCR, HSJD and HVH | 641 (123.2) | 497 (95.1) | 0.77 (0.69–0.87) | <0.0001 |
IPD cases | 57 (11.0) | 20 (3.8) | 0.35 (0.21–0.57) | <0.0001 |
PCV13 serotypes | 25 (4.8) | 10 (1.9) | 0.40 (0.18–0.82) | 0.01 |
Serotype 3 | 17 (3.3) | 9 (1.7) | 0.53 (0.22–1.17) | 0.07 |
Non-PCV13 serotypes |
29 (5.6) |
10 (1.9) |
0.34 (0.17–0.70) |
0.003 |
0–4 y | ||||
Emergency department visits | 108,757 (93,016.7) | 68,684 (60,617.9) | 0.65 (0.64–0.66) | <0.0001 |
Hospital admissions | 6,519 (5,575.5) | 4,256 (3,756.2) | 0.67 (0.65–0.70) | <0.0001 |
Samples for culture, HSJD | ND | ND | NA | NA |
Samples for PCR, HSJD and HVH | 459 (392.6) | 342 (301.8) | 0.77 (0.67–0.88) | 0.0002 |
IPD cases | 44 (37.6) | 15 (13.2) | 0.35 (0.19–0.62) | 0.0001 |
PCV13 serotypes | 18 (15.4) | 8 (7.1) | 0.46 (0.19–1.04) | 0.06 |
Serotype 3 | 12 (10.3) | 8 (7.1) | 0.69 (0.27–1.69) | 0.42 |
Non-PCV13 serotypes |
25 (21.4) |
7 (6.2) |
0.29 (0.12–0.67) |
0.002 |
5–17 y | ||||
Emergency department visits | 118,391 (29,353.5) | 79,953 (19,530.7) | 0.66 (0.65–0.67) | <0.0001 |
Hospital admissions | 4,794 (1,188.6) | 4,167 (1,017.9) | 0.86 (0.82–0.89) | <0.0001 |
Samples for culture. (HSJD | ND | ND | NA | NA |
Samples for PCR. HSJD and HVH | 182 (45.1) | 155 (37.9) | 0.84 (0.68–1.04) | 0.11 |
IPD cases | 13 (3.2) | 5 (1.2) | 0.38 (0.13–1.06) | 0.06 |
PCV13 serotypes | 7 (1.7) | 2 (0.5) | 0.28 (0.06–1.36) | 0.17 |
Serotype 3 | 5 (1.2) | 1 (0.2) | 0.20 (0.02–1.69) | 0.21 |
Non-PCV13 serotypes | 4 (1.0) | 3 (0.7) | 0.74 (0.16–3.30) | 0.71 |
*HSJD, Hospital Sant Joan de Dèu; HVH, Hospital Vall Hebron; IPD, invasive pneumococcal disease; IRR, incidence rate ratio; NA, not applicable; ND, not done; PCV13, 13-valent pneumococcal conjugate vaccine.